Glutamine supplementation to prevent morbidity and mortality in preterm infants.

ABSTRACT:

Background

Glutamine is a conditionally essential amino acid. Endogenous biosynthesis may be insufficient for tissue needs in states of metabolic stress. Evidence exists that glutamine supplementation improves clinical outcomes in critically ill adults. It has been suggested that glutamine supplementation may also benefit preterm infants.

Objectives

To determine the effects of glutamine supplementation on mortality and morbidity in preterm infants.

Search methods

We used the standard search strategy of the Cochrane Neonatal Review Group. This included searches of the Cochrane Central Register of Controlled Trials (CENTRAL, 2015, Issue 12), MEDLINE, EMBASE and Maternity and Infant Care (to December 2015), conference proceedings and previous reviews.

Selection criter

SUBMITTER: Moe-Byrne T 

PROVIDER: S-EPMC7055588 | biostudies-literature | 2016 Apr

REPOSITORIES: biostudies-literature